These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 36385444)

  • 21. Prognostic significance of lymph node metastases in small intestinal neuroendocrine tumors.
    Kim MK; Warner RR; Ward SC; Harpaz N; Roayaie S; Schwartz ME; Itzkowitz S; Wisnivesky J
    Neuroendocrinology; 2015; 101(1):58-65. PubMed ID: 25572143
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular lymph node staging for bladder cancer patients undergoing radical cystectomy with pelvic lymph node dissection.
    Heck MM; Koll FJ; Retz M; Autenrieth M; Magg K; Lunger L; Gschwend JE; Nawroth R
    Urol Oncol; 2020 Jul; 38(7):639.e11-639.e19. PubMed ID: 32146127
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Surgical Management of Small Bowel Neuroendocrine Tumors: Specific Requirements and Their Impact on Staging and Prognosis.
    Pasquer A; Walter T; Hervieu V; Forestier J; Scoazec JY; Lombard-Bohas C; Poncet G
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S742-9. PubMed ID: 26014153
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Extranodal extension is a powerful prognostic factor in bladder cancer patients with lymph node metastasis.
    Fajkovic H; Cha EK; Jeldres C; Robinson BD; Rink M; Xylinas E; Chromecki TF; Breinl E; Svatek RS; Donner G; Tagawa ST; Tilki D; Bastian PJ; Karakiewicz PI; Volkmer BG; Novara G; Joual A; Faison T; Sonpavde G; Daneshmand S; Lotan Y; Scherr DS; Shariat SF
    Eur Urol; 2013 Nov; 64(5):837-45. PubMed ID: 22877503
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Predictive Factors for Lymph Node Metastasis and Prognostic Factors for Survival in Rectal Neuroendocrine Tumors.
    Sohn B; Kwon Y; Ryoo SB; Song I; Kwon YH; Lee DW; Moon SH; Park JW; Jeong SY; Park KJ
    J Gastrointest Surg; 2017 Dec; 21(12):2066-2074. PubMed ID: 29047070
    [TBL] [Abstract][Full Text] [Related]  

  • 26. New Nodal Staging for Primary Pancreatic Neuroendocrine Tumors: A Multi-institutional and National Data Analysis.
    Zhang XF; Xue F; Dong DH; Lopez-Aguiar AG; Poultsides G; Makris E; Rocha F; Kanji Z; Weber S; Fisher A; Fields R; Krasnick BA; Idrees K; Smith PM; Cho C; Beems M; Lv Y; Maithel SK; Pawlik TM
    Ann Surg; 2021 Jul; 274(1):e28-e35. PubMed ID: 31356277
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Outcomes of radical cystectomy with extended lymphadenectomy alone in patients with lymph node-positive bladder cancer who are unfit for or who decline adjuvant chemotherapy.
    Zehnder P; Studer UE; Daneshmand S; Birkhäuser FD; Skinner EC; Roth B; Miranda G; Burkhard FC; Cai J; Skinner DG; Thalmann GN; Gill IS
    BJU Int; 2014 Apr; 113(4):554-60. PubMed ID: 24131453
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association of Lymph Node Status With Survival in Patients After Liver Resection for Hilar Cholangiocarcinoma in an Italian Multicenter Analysis.
    Giuliante F; Ardito F; Guglielmi A; Aldrighetti L; Ferrero A; Calise F; Giulini SM; Jovine E; Breccia C; De Rose AM; Pinna AD; Nuzzo G
    JAMA Surg; 2016 Oct; 151(10):916-922. PubMed ID: 27556741
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lymphadenectomy for high-grade endometrial cancer: Does it impact lymph node recurrence?
    Swift BE; Philp L; Atenafu EG; Malkani N; Gien LT; Bernardini MQ
    Eur J Surg Oncol; 2022 May; 48(5):1181-1187. PubMed ID: 34782183
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Critical evaluation of the American Joint Committee on Cancer TNM nodal staging system in patients with lymph node-positive disease after radical cystectomy.
    Bruins HM; Dorin RP; Rubino B; Miranda G; Cai J; Daneshmand S; Skinner EC
    Eur Urol; 2012 Oct; 62(4):671-6. PubMed ID: 22575915
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Resection of at-risk mesenteric lymph nodes is associated with improved survival in patients with small bowel neuroendocrine tumors.
    Landry CS; Lin HY; Phan A; Charnsangavej C; Abdalla EK; Aloia T; Nicolas Vauthey J; Katz MH; Yao JC; Fleming JB
    World J Surg; 2013 Jul; 37(7):1695-700. PubMed ID: 23657749
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognostic factors for disease relapse in patients with neuroendocrine tumours who underwent curative surgery.
    Slagter AE; Ryder D; Chakrabarty B; Lamarca A; Hubner RA; Mansoor W; O'Reilly DA; Fulford PE; Klümpen HJ; Valle JW; McNamara MG
    Surg Oncol; 2016 Sep; 25(3):223-8. PubMed ID: 27566026
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Factors predictive of pelvic lymph node involvement and outcomes in melanoma patients with metastatic sentinel lymph node of the groin: A multicentre study.
    Mozzillo N; Pasquali S; Santinami M; Testori A; Di Marzo M; Crispo A; Patuzzo R; Verrecchia F; Botti G; Montella M; Rossi CR; Caracò C
    Eur J Surg Oncol; 2015 Jul; 41(7):823-9. PubMed ID: 25800935
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gastric neuroendocrine neoplasms type 1: A systematic review and meta-analysis.
    Tsolakis AV; Ragkousi A; Vujasinovic M; Kaltsas G; Daskalakis K
    World J Gastroenterol; 2019 Sep; 25(35):5376-5387. PubMed ID: 31558880
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic implications of extracapsular extension of pelvic lymph node metastases in urothelial carcinoma of the bladder.
    Fleischmann A; Thalmann GN; Markwalder R; Studer UE
    Am J Surg Pathol; 2005 Jan; 29(1):89-95. PubMed ID: 15613859
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association between factor of parotid lymph node and prognosis in parotid cancer.
    Fang Q; Zhang X; Dai L; Luo R; Yuan J
    Eur J Surg Oncol; 2023 Aug; 49(8):1405-1410. PubMed ID: 37061402
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lymph node dissection and survival in patients with early stage nonsmall cell lung cancer: A 10-year cohort study.
    Shen-Tu Y; Mao F; Pan Y; Wang W; Zhang L; Zhang H; Cheng B; Guo H; Wang Z
    Medicine (Baltimore); 2017 Oct; 96(43):e8356. PubMed ID: 29069017
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Redefining the Ki-67 Index Stratification for Low-Grade Pancreatic Neuroendocrine Tumors: Improving Its Prognostic Value for Recurrence of Disease.
    Lopez-Aguiar AG; Ethun CG; Postlewait LM; Zhelnin K; Krasinskas A; El-Rayes BF; Russell MC; Sarmiento JM; Kooby DA; Staley CA; Maithel SK; Cardona K
    Ann Surg Oncol; 2018 Jan; 25(1):290-298. PubMed ID: 29079920
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Toward a Preoperative Classification of Lymph Node Metastases in Patients with Small Intestinal Neuroendocrine Tumors in the Era of Intestinal-Sparing Surgery.
    Lardière-Deguelte S; de Mestier L; Appéré F; Vullierme MP; Zappa M; Hoeffel C; Noaves M; Brixi H; Hentic O; Ruszniewski P; Cadiot G; Panis Y; Kianmanesh R
    Neuroendocrinology; 2016; 103(5):552-9. PubMed ID: 26445315
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lymphadenectomy during Small Bowel Neuroendocrine Tumor Surgery: The Concept of Skip Metastases.
    Pasquer A; Walter T; Rousset P; Hervieu V; Forestier J; Lombard-Bohas C; Poncet G
    Ann Surg Oncol; 2016 Dec; 23(Suppl 5):804-808. PubMed ID: 27613554
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.